“…National Statement)Vulnerable because: • Vulnerability may arise because of discovery of participants’ illegal activity [34] | Those with diminished capacity for self-determination (TCPS2) | • Historically vulnerable and “have, at times, been treated unfairly and inequitably in research, or have been excluded from research opportunities” a ([35], p. 8) |
The least organizationally developed communities (TCPS2) | Vulnerable to: • Exploitation [35] |
Grouped by patient/participant condition |
Children, minors, or young people (CIOMS, Clinical Trials Directive, Clinical Trials Regulation, Aus. National Statement, TCPS2, Common Rule) | Vulnerable because: • Limited freedom or capacity to consent [29, 35] • Vulnerability arising from developmental stage [35] • No explanation [31, 32] • Explanation unclear [34] Vulnerable to: • Coercion or undue influence [38] |
Persons with mental illness or mental health problems (Clinical Trials Regulation, Aus. National Statement, TCPS2, UK Research Governance Framework) | Vulnerable because: • Historically considered vulnerable and “have, at times, been treated unfairly and inequitably in research, or have been excluded from research opportunities” a ([35], p. 8) • Unclear [32, 36] Vulnerable to: • Various forms of discomfort and stress [34] |
Elderly persons (CIOMS, Clinical Trials Regulation, TCPS2) | Vulnerable because: • Likely to acquire “vulnerability-defining” traits (e.g., institutionalization, dementia) ([29], p. 65] • Historically considered a group in vulnerable circumstances “have, at times, been treated unfairly and inequitably in research, or have been excluded from research opportunities” a ([35], p. 8) • No explanation [32] |
Persons with limited (or no) freedom or capacity to consent (CIOMS, Clinical Trials Regulation, ICH GCP) | Vulnerable because: • Relatively (or absolutely) incapable of protecting their own interests [29] • No explanation [32] • Explanation unclear [33] Vulnerable to: • Exploitation for financial gain by guardians [29] |
Pregnant or breastfeeding women (Clinical Trials Regulation, Common Rule) | Vulnerable to: • Coercion or undue influence [38] • No explanation [32] |
Adults with learning difficulties (UK Research Governance Framework) | • No explanation [36] |
Handicapped persons (Common Rule) | • No explanation [38] |
Mentally disabled persons (Common Rule) | Vulnerable to: • Coercion or undue influence [38] |
Pers... |
…”